Cano Health, LLC owns and operates health care centers and pharmacies. It provides medical, dental, urgent care, an in-house laboratory, and specialty services. The company offers patient-centric programs, such as home visits, telehealth, transition of care, and high risk and complex care management. Cano Health, LLC was founded in 2009 and is based in Miami, Florida.
IPO Year: 2020
Exchange: NYSE
Website: canohealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/11/2023 | Buy → Hold | Jefferies | |
| 8/11/2023 | $4.00 → $0.80 | Buy → Neutral | Citigroup |
| 1/6/2023 | $12.00 → $1.25 | Buy → Neutral | UBS |
| 1/5/2023 | Outperform → Peer Perform | Wolfe Research | |
| 12/13/2022 | $1.50 | Underperform | BofA Securities |
| 11/10/2022 | $10.00 → $3.00 | Outperform → Market Perform | Cowen |
| 11/10/2022 | Outperform → Mkt Perform | Raymond James | |
| 10/27/2022 | $10.00 → $5.00 | Outperform → Neutral | Credit Suisse |
| 9/7/2022 | $7.00 | Hold | Truist |
| 6/24/2022 | $8.00 | Outperform | Raymond James |
8-K - Cano Health, Inc. (0001800682) (Filer)
8-K - Cano Health, Inc. (0001800682) (Filer)
25-NSE - Cano Health, Inc. (0001800682) (Subject)
8-K - Cano Health, Inc. (0001800682) (Filer)
8-K - Cano Health, Inc. (0001800682) (Filer)
144 - Cano Health, Inc. (0001800682) (Subject)
8-K - Cano Health, Inc. (0001800682) (Filer)
144 - Cano Health, Inc. (0001800682) (Subject)
8-K - Cano Health, Inc. (0001800682) (Filer)
144 - Cano Health, Inc. (0001800682) (Subject)
Emergence from Chapter 11 Expected in Third Quarter of 2024 MIAMI, May 21, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced a global agreement with the Unsecured Creditors Committee representing the interests of the Company's general unsecured creditors, with the support of the Ad Hoc Lender Group. It also received approval of its Disclosure Statement by the U.S. Bankruptcy Court for the District of Delaware (the "Court"), paving the way to solicit creditor approval of its Plan of Reorganization and its expected emergence from Chapter 11 in the third quarter. Mark
MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the Company that the NYSE had determined to (a) commence proceedings to delist the Company's Class A common stock, par value $0.01 per share ("Common Stock") and (b) immediately suspend trading in the Company's Common Stock pursuant to Section 802.01D of the NYSE Listed Company Manual after the Company filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on February 4, 2024.
Positions the Company to Advance Its Ongoing Transformation Plan Designed to Significantly Reduce Costs, Enhance Productivity, and Improve Cash Flow Receives Commitment for $150 Million in New Capital Ensures Patients Continue to Receive High-Quality Care Across Medical Centers MIAMI, Feb. 4, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that it has entered into a Restructuring Support Agreement (the "RSA") with lenders (the "Ad Hoc Lender Group") holding approximately 86% of its secured revolving and term loan debt and 92% of its senior unsecured notes. This a
Accelerates Transformation Plan, Now Targeting $290 million of Cost Reductions MIAMI, Dec. 29, 2023 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company") announced today that it was notified by NYSE Regulation Inc. (the "NYSE") that it is not in compliance with Section 802.01B of the NYSE Listed Company Manual (the "Listing Rule") because the Company's total market capitalization has been less than $50 million over a 30 trading-day period and its stockholders' equity is less than $50 million. Pursuant to the Listing Rule, the Company has 10 business d
Patricia Ferrari and Carol Flaton to Enhance the Board's and Management's Ongoing Strategic, Operational and Financing Initiatives MIAMI, Dec. 18, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE:CANO), a leading value-based primary care provider and population health company, today announced the appointment of Patricia Ferrari and Carol Flaton to its Board of Directors. Ms. Ferrari and Ms. Flaton bring broad business experience and deep financial expertise, with proven track records of advising companies on strategies to improve operations and financial performance, as well as strengthening their capital structures.
MIAMI, Oct. 5, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE:CANO) today announced that it has filed a preliminary proxy statement with the SEC regarding a special stockholders' meeting to authorize Cano Health's Board of Directors to effect a reverse stock split of the Company's Class A and Class B common stock (the "Common Stock") at a ratio of 1-for-60, with the Board having the right to adjust such ratio down to 1-for-5 and up to 1-for-100 (the "Reverse Stock Split"). The Board will determine the final split ratio after stockholder approval and would retain the authority to abandon the Reverse Stock Split at any time or to delay or postpone it.
Eladio Gil named Interim Chief Financial Officer MIAMI, Sept. 29, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE:CANO) today announced that Eladio Gil has been appointed Interim Chief Financial Officer, effective September 29, 2023. Mr. Gil, who previously served as Cano Health's Vice President of Medicare Advantage Finance, succeeds Brian Koppy, who has stepped down to accept an opportunity outside the organization. Mr. Gil is a seasoned finance executive with more than 30 years of comprehensive healthcare experience. Before joining Cano Health, Mr. Gil served a
MIAMI, Sept. 26, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE:CANO) today announced that it sold substantially all of the assets associated with the operation of Cano Health's senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care ("CenterWell"). The total value of the transaction to Cano Health is approximately $66.7 million, consisting of approximately $35.4 million in cash paid at closing (of which approximately $1.9 million was withheld for satisfaction of potential indemnification claims), plus the release of certain liabilities owed by Cano Health. As of August 1, 2023, the primary care centers in Texas and Nevada cared for approximate
MIAMI, Sept. 11, 2023 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company" announced today that it was notified by NYSE Regulation Inc. (the "NYSE") that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual (the "Listing Rule") because the average closing stock price of a share of the Company's Class A common stock was less than $1.00 per share over a consecutive 30 trading-day period. Pursuant to the Listing Rule, the Company has 6 months following the NYSE notification to regain compliance with the Listing Rule, during which
Mr. Kent immediately joins Board of Directors, replacing Dr. Marlow Hernandez who has stepped down MIAMI, Aug. 21, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that its Board of Directors has appointed Mark Kent as Chief Executive Officer, effective immediately. The Board also elected Mr. Kent, who has served as interim Chief Executive Officer since June 16, 2023, to Cano Health's Board of Directors. The Board also announced that Dr. Marlow Hernandez has stepped down from the Board effective immediately. Regarding Mr. Kent's appointment, the Board issued the following state